Evidence map›Paper›PMID 26433879›Full record

ArticlePathology oncology research : POR2016

The role of mannose binding lectin on fever episodes in pediatric oncology patients.

Ferenc Fekete, Balázs Fadgyas, Éva Papp, Ágnes Szilágyi, Zoltán Prohászka, Brigitta Müller, Gábor Kovács

Abstract read
PubMed Publisher
In one paragraph

Article in Pathology oncology research : POR, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Genetic Sequence Variants inChildren (Basel, Switzerland) · 2020
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ferenc FeketeDepartment of Hematology, Heim Pál Children's Hospital, Madarász Street Building, Madarász utca 22-24, Budapest, 1131, Hungary. efekete@heimpalkorhaz.hu.
Balázs FadgyasDepartment of Pediatric Surgery and Traumatology, Heim Pál Children's Hospital, Budapest, Hungary.
Éva PappNational Institute of Psychiatry and Addictions, Gyula Nyírő Hospital, Budapest, Hungary.
Ágnes Szilágyi3rd Department of Internal Medicine, Research Laboratory, Semmelweis University, Budapest, Hungary.
Zoltán Prohászka3rd Department of Internal Medicine, Research Laboratory, Semmelweis University, Budapest, Hungary.
Brigitta MüllerDepartment of Hematology, Heim Pál Children's Hospital, Madarász Street Building, Madarász utca 22-24, Budapest, 1131, Hungary.
Gábor Kovács2nd Department of Pediatrics, Hematology Unit, Semmelweis University, Budapest, Hungary.
Heim Pál Gyermekkórház · HUSemmelweis University · HUNational Institute of Menthal Health, Neurology and Neurosurgery - Nyírő Gyula Hospital · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite significant changes in pediatric oncological therapy, mortality is still high, mainly due to infections. Complement system as an ancient immune defense against microorganisms plays a significant role in surmounting infections, therefore, deficiency of its components may have particular importance in malignancies. The present paper assesses the effect of promoter (X/Y) and exon 1 (A/0) polymorphisms of the MBL2 gene altering mannose binding lectin (MBL) serum level in pediatric oncological patients with febrile neutropenia. Furthermore, frequency distribution of MBL2 alleles in children with malignancies and age-matched controls was analysed. Fifty-four oncohematological patients and 53 children who had undergone pediatric surgery were enrolled into this retrospective study. No significant differences were found in the frequency of MBL2 alleles between the hemato-oncologic and control group. The average duration of fever episodes was significantly shorter (p = 0.035) in patients carrying genotypes (AY/AY and AY/AX) that encode normal MBL level, compared to individuals with genotypes associated with lower functional MBL level (AX/AX, AY/0, AX/0, or 0/0) (days, median (IQ range) 3.7(0-5.4) vs. 5.0(3.8-6.6), respectively). In conclusion, our data suggest that MBL2 genotypes may influence the course of febrile neutropenia in pediatric patients with malignancies, and may contribute to clarification of the importance of MBL in infections.

Indexed as

AdolescentBiomarkers, TumorChildChild, PreschoolFebrile NeutropeniaFemaleFollow-Up StudiesHumansInfantMaleMannose-Binding LectinNeoplasmsNeoplasm StagingPolymorphism, Single NucleotidePrognosisRetrospective StudiesBiomarkers, TumorMannose-Binding LectinMBL2 protein, humanFebrile neutropeniaMBLOncohematologyPolymorphism

Identifiers

PMID26433879
OpenAlexW2173352706

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.